SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000043
Filing Date
2007-05-11
Accepted
2007-05-11 11:00:57
Documents
2
Period of Report
2007-05-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR ODAC PANEL MAY 9, 2007 odacpanel.htm 8-K 20984
2 PRESS RELEASE DOR ODAC MEETING pressreleaseodacpanel.htm EX-99.1 34756
  Complete submission text file 0000812796-07-000043.txt   57435
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 07840585
SIC: 2834 Pharmaceutical Preparations